| IFAT | ELISA | WB | |||
---|---|---|---|---|---|---|
 | Median | CI | Median | CI | Median | CI |
Non-endemic area: sample prevalence 0.02% (CI: 0.00–0.16) | ||||||
 Sensitivity | 0.33 | 0.01–0.96 | 0.38 | 0.02–0.97 | 0.41 | 0.02–0.96 |
 Specificity | 0.99 | 0.94–1.00 | 0.98 | 0.92–1.00 | 0.96 | 0.90–0.99 |
Endemic area: sample prevalence 0.10% (CI: 0.01–0.96) | ||||||
 Sensitivity | 0.43 | 0.07–0.93 | 0.26 | 0.00–0.94 | 0.64 | 0.07–0.99 |
 Specificity | 0.84 | 0.18–0.95 | 0.98 | 0.30–1.00 | 0.84 | 0.06–0.96 |
Affected by leishmaniosis: sample prevalence 0.89% (CI: 0.01–1.00) | ||||||
 Sensitivity | 0.89 | 0.08–0.99 | 0.94 | 0.13–1.00 | 0.94 | 0.09–1.00 |
 Specificity | 0.21 | 0.01–0.95 | 0.18 | 0.00–0.93 | 0.16 | 0.00–0.94 |